Among the key PTS points for the 21st, タスキＨＤ was reported to have raised its consolidated operating profit forecast for the fiscal year ending September 2026, while 西松屋チェ reported a year-on-year decline in October same-store sales.
タスキＨＤ raised its consolidated operating profit forecast for the fiscal year ending September 2026 from ¥11.0 billion to ¥13.65 billion. The revision is reportedly due to project selling prices significantly exceeding initial assumptions.
岡野バル raised its consolidated operating profit forecast for the fiscal year ending September 2026 from ¥1.95 billion to ¥2.6 billion and increased its annual dividend forecast from ¥80 to ¥110.
西松屋チェ's October same-store sales, for the period ended 20 October, fell 5.6% year on year, with sales of winter clothing remaining weak. Other stocks mentioned included デジターツ, where traces of unauthorized access were discovered, and ロジザード, which launched a common digital shipping-tag service.
オービーシス reported consolidated operating profit of ¥310 million for the six months ended the second quarter of the fiscal year ending March 2027, up 45.8% year on year. ラクオリア薬 received a milestone payment associated with the start of Phase 2 clinical trials for a novel sodium-channel blocker. Developments at アジュバンＨ, セブン工 and ストライクＧ also attracted attention as major earnings and earnings-revision information.